FC
ELV icon

Fore Capital’s Elevance Health ELV Stock Holding History

Fore Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,000
Closed -$1.29M – 56
2025
Q3 		$1.29M Buy
+4,000
New +$1.24M 0.37% 30
2024
Q1 		– Sell
-1,500
Closed -$707K – 49
2023
Q4 		$707K Buy
+1,500
New +$694K 0.35% 27

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Fore Capital's ELV Position: Q4 2025 in Review

Fore Capital sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 4,000 shares — an estimated $1.29M sold.

Fore Capital first reported a position in ELV in Q4 2023 and held it in 2 quarters. The position peaked at $1.29M in Q3 2025. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Fore Capital reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Fore Capital sold 4,000 Elevance Health shares in Q4 2025, an estimated $1.29M.
  • Fore Capital first reported a position in Elevance Health in Q4 2023 and held it in 2 quarters.
  • Fore Capital's Elevance Health position peaked at $1.29M in Q3 2025.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Fore Capital's 13F filing for Q4 2025, filed 11 Feb 2026.